Abstract: An authentication system may receive a request signature corresponding to a user request to view secure user information on a user device and generate a server-side signature matching the request signature to authenticate the user device to receive the secure user information without authenticating the user. The request signature may include a device identifier corresponding to the device, a token code generated by the authentication system and stored by the user device, a timestamp corresponding to the transmission time of the request signature, and a version of the device identifier, the token code, and the timestamp encrypted using a signature key provided to the user device by the authentication system. The authentication system may generate the server-side signature using the timestamp and stored copies of the device identifier, the token code, and the signature key.

Abstract: Based upon a strong correlation between regulator T cells (Treg cells) and suppressing or preventing a cytotoxic T cell response, provided are methods for the production of ex vivo activated and culture-expanded isolated CD4+CD25+ suppressor Treg cells for the prevention or suppression of immune reactions in a host, particularly in a human host, and including autoimmune responses. The resulting ex vivo culture-expanded Treg cells provide a sufficient amount of otherwise low numbers of such cells, having long term suppressor capability to permit therapeutic uses, including the preventing, suppressing, blocking or inhibiting the rejection of transplanted tissue in a human or other animal host, or protecting against graft vs host disease. Also provided are therapeutic and immunosuppressive methods utilizing the ex vivo culture-expanded Treg cells for human treatment, and high efficiency methods for research use.

Abstract: Based upon a strong correlation between regulator T cells (Treg cells) and suppressing or preventing a cytotoxic T cell response, provided are methods for the production of ex vivo activated and culture-expanded isolated CD4+CD25+ suppressor Treg cells for the prevention or suppression of immune reactions in a host, particularly in a human host, and including autoimmune responses. The resulting ex vivo culture-expanded Treg cells provide a sufficient amount of otherwise low numbers of such cells, having long term suppressor capability to permit therapeutic uses, including the preventing, suppressing, blocking or inhibiting the rejection of transplanted tissue in a human or other animal host, or protecting against graft vs host disease. Also provided are therapeutic and immunosuppressive methods utilizing the ex vivo culture-expanded Treg cells for human treatment, and high efficiency methods for research use.

Abstract: Based upon a strong correlation between regulator T cells (Treg cells) and suppressing or preventing a cytotoxic T cell response, provided are methods for the production of ex vivo activated and culture-expanded isolated CD4+CD25+ suppressor Treg cells for the prevention or suppression of immune reactions in a host, particularly in a human host, and including autoimmune responses. The resulting ex vivo culture-expanded Treg cells provide a sufficient amount of otherwise low numbers of such cells, having long term suppressor capability to permit therapeutic uses, including the preventing, suppressing, blocking or inhibiting the rejection of transplanted tissue in a human or other animal host, or protecting against graft vs host disease. Also provided are therapeutic and immunosuppressive methods utilizing the ex vivo culture-expanded Treg cells for human treatment, and high efficiency methods for research use.

Abstract: An online system and method for improving individual hand hygiene practices includes a central program manager including a processing unit, server, and memory necessary for interactive internet communication with a host of users. Each user or participant may access the software program when, where and however she/he desires, provided internet access is available. The online learning system and method maintained by the program manager is divided into three sessions, each comprising a module, each module being tailored to educate the participant about hand hygiene practices and to elicit from the participant a self-assessment of any shortcomings that the participant may perceive himself/herself as having in the area of hand hygiene.

Abstract: Based upon a strong correlation between regulator T cells (Treg cells) and suppressing or preventing a cytotoxic T cell response, provided are methods for the production of ex vivo activated and culture-expanded isolated CD4+CD25+ suppressor Treg cells for the prevention or suppression of immune reactions in a host, particularly in a human host, and including autoimmune responses. The resulting ex vivo culture-expanded Treg cells provide a sufficient amount of otherwise low numbers of such cells, having long term suppressor capability to permit therapeutic uses, including the preventing, suppressing, blocking or inhibiting the rejection of transplanted tissue in a human or other animal host, or protecting against graft vs host disease. Also provided are therapeutic and immunosuppressive methods utilizing the ex vivo culture-expanded Treg cells for human treatment, and high efficiency methods for research use.

Abstract: Based upon a strong correlation between regulator T cells (Treg cells) and suppressing or preventing a cytotoxic T cell response, provided are methods for the production of ex vivo activated and culture-expanded isolated CD4+CD25+ suppressor Treg cells for the prevention or suppression of immune reactions in a host, particularly in a human host, and including autoimmune responses. The resulting ex vivo culture-expanded Treg cells provide a sufficient amount of otherwise low numbers of such cells, having long term suppressor capability to permit therapeutic uses, including the preventing, suppressing, blocking or inhibiting the rejection of transplanted tissue in a human or other animal host, or protecting against graft vs host disease. Also provided are therapeutic and immunosuppressive methods utilizing the ex vivo culture-expanded Treg cells for human treatment, and high efficiency methods for research use.

Abstract: A method for assessing improvement in hand hygiene practices using sanitation solution dispensers deployed within particular areas of interest in a healthcare facility or the like. Each of the dispensers has a counter associated therewith, with the counter producing a count indicative of actual events of a healthcare worker sanitizing his/her hands. Other data is acquired that impacts the number of anticipated hand sanitation events in this particular area of interest. From this data, a number of anticipated hand sanitation events is determined. Finally, a determination is made, from information obtained through actual observation, of the number of opportunities that healthcare workers will have for hand sanitation in the area of interest over a particular period of time.

Abstract: A method for assessing improvement in hand hygiene practices using sanitation solution dispensers deployed within particular areas of interest in a healthcare facility or the like. Each of the dispensers has a counter associated therewith, with the counter producing a count indicative of actual events of a healthcare worker sanitizing his/her hands. Other data is acquired that impacts the number of anticipated hand sanitation events in this particular area of interest. From this data, a number of anticipated hand sanitation events is determined. Finally, a determination is made, from information obtained through actual observation, of the number of opportunities that healthcare workers will have for hand sanitation in the area of interest over a particular period of time.

Abstract: A method to effect behavioral change with regard to good hand hygiene practices is disclosed. The methodology employs staged and stratified tools of education, triggers of awareness, leadership development, personal engagement, feedback, reinforcement, and the provision of outside support matched to stages of individual and cultural change. The program stages through a pre-launch period, a launch period, a concentrated period of culture change, and a process for maintaining the culture thereafter. Each stage involves various tools and various personnel to achieve the desired result of good hand hygiene practices being a way of life, rather than a weak periodic focus that can threaten safety and quality of patient care.

Abstract: Based upon a strong correlation between regulator T cells (Treg cells) and suppressing or preventing a cytotoxic T cell response, provided are methods for the production of ex vivo activated and culture-expanded isolated CD4+CD25+ suppressor Treg cells for the prevention or suppression of immune reactions in a host, particularly in a human host, and including autoimmune responses. The resulting ex vivo culture-expanded Treg cells provide a sufficient amount of otherwise low numbers of such cells, having long term suppressor capability to permit therapeutic uses, including the preventing, suppressing, blocking or inhibiting the rejection of transplanted tissue in a human or other animal host, or protecting against graft vs host disease. Also provided are therapeutic and immunosuppressive methods utilizing the ex vivo culture-expanded Treg cells for human treatment, and high efficiency methods for research use.

Abstract: The present invention provides a communicative glove which includes means for monitoring the glove's integrity such that a breach of the glove's barrier may be detected, or in some cases anticipated, and thus a warning may be provided to the wearer of the breach.

Abstract: The present invention provides a communicative glove which includes means for monitoring the glove's integrity such that a breach of the glove's barrier may be detected, or in some cases anticipated, and thus a warning may be provided to the wearer of the breach.

Abstract: The present invention provides a communicative glove which includes means for monitoring the glove's integrity such that a breach of the glove's barrier may be detected, or in some cases anticipated, and thus a warning may be provided to the wearer of the breach.

Abstract: Methods for inducing T-cell non-responsiveness to donor T-cells comprised in transplantation tissues are provided. The methods involve ex vivo treatment of donor T-cells with gp39 antagonists.

Abstract: Methods for inducing T-cell non-responsiveness to donor T-cells comprised in transplantation tissues are provided. The methods involve ex vivo treatment of donor T-cells with gp39 antagonists.

Abstract: The present invention provides a communicative glove which includes means for monitoring the glove's integrity such that a breach of the glove's barrier may be detected, or in some cases anticipated, and thus a warning may be provided to the wearer of the breach.